A simple inflammation model that distinguishes between the actions of anti-inflammatory and anti-rheumatic drugs
✍ Scribed by E. J. Lewis; J. Bishop; S. J. Aspinall
- Publisher
- SP Birkhäuser Verlag Basel
- Year
- 1998
- Tongue
- English
- Weight
- 170 KB
- Volume
- 47
- Category
- Article
- ISSN
- 1420-908X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In the present study we used the model of cultured somatostatin-receptor-positive prolactin (PRL)-secreting rat pituitary tumor cells to investigate the possible interrelationships between the anti-mitotic and horrnone-releaseinhibitory effects of the somatostatin analog octreotide (SMS 201-955) and
E3040, a new class of anti-inflammatory drug, was found to reduce the plasma uric acid level in the first phase of clinical studies. In the present study, the mechanism of the uricosuric action of E3040 was investigated using the hyperuricemia model rat. The fractional excretion of uric acid (FE ura